Design Idea of 'ultra Hypotoxic Multidrug' Based on the “efficacy Theory” of Traditional Chinese Medicines

S. Q. Cai,X. Feng,M. Y. Shang,X. Wang

DOI: https://doi.org/10.1055/s-0036-1597017

IF: 3.007

2016-01-01

Planta Medica

Abstract:We provide here a traditional Chinese medicines (TCMs) efficacy theory [1]: “A TCMs exerts its effect through both the additive effects of numerous effective forms (EFs, including constituents or/and their metabolites) on the same target and the synergistic effects based on the overall action of the additive effects on individual targets (Fig. 1), and the TCMs weakens its toxicities through their toxicity scattering effects (Fig. 2). ”Since a TCMs may include 1000 constituents and each constituent may produce 100 metabolites in vivo after administration, we consider that numerous EFs among incalculable constituents and their metabolites could work together; when the quantity of molecules of a target is larger than that of the drug molecules, the molecules of different EFs could combine with the molecules of the target successively, to exert the additive effects; when the target molecules are mostly occupied, the TCMs begins to work. The additive effects and the toxicity scattering effects of the EFs are resulted from the same efficacy centers and not identical toxic centers among the structures of different EFs. Based on the assumption that all EFs possess different structures and thereby their toxicities are more or less different from one another and based on the assumption that each active compound can act on the same target, we can design a combination drug that is composed of over 10 active compounds, and as a result the amount of each compound can be reduced to below 1/10, and therefore their toxicities will be reduced to 1/10 or less. In addition, 3 – 5 groups (over 10 compounds for each) which can act on different targets of the same disease, can be chosen to form a much bigger combination with over 30 – 50 compounds, which should have great advantages of high efficiency of multiple targets and significantly reduced toxicity and this is called ultra hypotoxic multidrug.